Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-012323
Filing Date
2022-06-03
Accepted
2022-06-03 16:58:28
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5620
  Complete submission text file 0001567619-22-012323.txt   7116
Mailing Address C/O MYOVANT SCIENCES INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
Curran Terrie (Reporting) CIK: 0001690298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 22995487

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations